70 related articles for article (PubMed ID: 25564360)
21. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
22. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
Lan F; Yu H; Hu M; Xia T; Yue X
J Neurochem; 2015 Oct; 135(2):274-86. PubMed ID: 26250785
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of anastomotic strength and drug safety after short-term sunitinib administration in rabbits.
Fallon EM; Nehra D; Carlson SJ; Brown DW; Nedder AP; Rueda BR; Puder M
J Surg Res; 2014 Mar; 187(1):101-6. PubMed ID: 24189178
[TBL] [Abstract][Full Text] [Related]
25. Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells.
Zhao Y; Xue T; Yang X; Zhu H; Ding X; Lou L; Lu W; Yang B; He Q
Toxicol Appl Pharmacol; 2010 Oct; 248(1):20-7. PubMed ID: 20637791
[TBL] [Abstract][Full Text] [Related]
26. Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.
Battle MR; Goggi JL; Allen L; Barnett J; Morrison MS
J Nucl Med; 2011 Mar; 52(3):424-30. PubMed ID: 21321268
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways.
Liu J; Albrecht AM; Ni X; Yang J; Li M
Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007
[TBL] [Abstract][Full Text] [Related]
28. Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells.
Suzhi Z; Liang T; Yuexia P; Lucy L; Xiaoting H; Yuan Z; Qin W
J Cell Physiol; 2015 Oct; 230(10):2476-88. PubMed ID: 25753094
[TBL] [Abstract][Full Text] [Related]
29. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
[TBL] [Abstract][Full Text] [Related]
30. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
31. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G
Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996
[TBL] [Abstract][Full Text] [Related]
32. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
33. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
Lakomy R; Sana J; Hankeova S; Fadrus P; Kren L; Lzicarova E; Svoboda M; Dolezelova H; Smrcka M; Vyzula R; Michalek J; Hajduch M; Slaby O
Cancer Sci; 2011 Dec; 102(12):2186-90. PubMed ID: 21895872
[TBL] [Abstract][Full Text] [Related]
34. Extensive modulation of a set of microRNAs in primary glioblastoma.
Ciafrè SA; Galardi S; Mangiola A; Ferracin M; Liu CG; Sabatino G; Negrini M; Maira G; Croce CM; Farace MG
Biochem Biophys Res Commun; 2005 Sep; 334(4):1351-8. PubMed ID: 16039986
[TBL] [Abstract][Full Text] [Related]
35. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
Wang G; Wang JJ; Tang HM; To SS
Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
[TBL] [Abstract][Full Text] [Related]
36. miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
Zhang W; Shen C; Li C; Yang G; Liu H; Chen X; Zhu D; Zou H; Zhen Y; Zhang D; Zhao S
Mol Carcinog; 2016 May; 55(5):575-85. PubMed ID: 25764520
[TBL] [Abstract][Full Text] [Related]
37. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
[TBL] [Abstract][Full Text] [Related]
38. Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma.
van Linde ME; Labots M; Brahm CG; Hovinga KE; De Witt Hamer PC; Honeywell RJ; de Goeij-de Haas R; Henneman AA; Knol JC; Peters GJ; Dekker H; Piersma SR; Pham TV; Vandertop WP; Jiménez CR; Verheul HMW
Clin Cancer Res; 2022 Apr; 28(8):1595-1602. PubMed ID: 35165100
[TBL] [Abstract][Full Text] [Related]
39. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
40. miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
Huang H; Sun P; Lei Z; Li M; Wang Y; Zhang HT; Liu J
Tumour Biol; 2015 Jun; 36(6):4123-31. PubMed ID: 25578496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
